These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37844867)

  • 1. Fluoroethylnormemantine (FENM) shows synergistic protection in combination with a sigma-1 receptor agonist in a mouse model of Alzheimer's disease.
    Freyssin A; Carles A; Guehairia S; Rubinstenn G; Maurice T
    Neuropharmacology; 2024 Jan; 242():109733. PubMed ID: 37844867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Amnesic and Neuroprotective Effects of Fluoroethylnormemantine in a Pharmacological Mouse Model of Alzheimer's Disease.
    Couly S; Denus M; Bouchet M; Rubinstenn G; Maurice T
    Int J Neuropsychopharmacol; 2021 Feb; 24(2):142-157. PubMed ID: 32977336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection by sigma-1 receptor agonists is synergic with donepezil, but not with memantine, in a mouse model of amyloid-induced memory impairments.
    Maurice T
    Behav Brain Res; 2016 Jan; 296():270-278. PubMed ID: 26386305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid toxicity is enhanced after pharmacological or genetic invalidation of the σ
    Maurice T; Strehaiano M; Duhr F; Chevallier N
    Behav Brain Res; 2018 Feb; 339():1-10. PubMed ID: 29129596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotection in non-transgenic and transgenic mouse models of Alzheimer's disease by positive modulation of σ
    Maurice T; Volle JN; Strehaiano M; Crouzier L; Pereira C; Kaloyanov N; Virieux D; Pirat JL
    Pharmacol Res; 2019 Jun; 144():315-330. PubMed ID: 31048034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoroethylnormemantine, A Novel Derivative of Memantine, Facilitates Extinction Learning Without Sensorimotor Deficits.
    Chen BK; Le Pen G; Eckmier A; Rubinstenn G; Jay TM; Denny CA
    Int J Neuropsychopharmacol; 2021 Jul; 24(6):519-531. PubMed ID: 33631001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoroethylnormemantine, a Novel NMDA Receptor Antagonist, for the Prevention and Treatment of Stress-Induced Maladaptive Behavior.
    Chen BK; Luna VM; Shannon ME; Hunsberger HC; Mastrodonato A; Stackmann M; McGowan JC; Rubinstenn G; Denny CA
    Biol Psychiatry; 2021 Oct; 90(7):458-472. PubMed ID: 34274107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pridopidine stabilizes mushroom spines in mouse models of Alzheimer's disease by acting on the sigma-1 receptor.
    Ryskamp D; Wu L; Wu J; Kim D; Rammes G; Geva M; Hayden M; Bezprozvanny I
    Neurobiol Dis; 2019 Apr; 124():489-504. PubMed ID: 30594810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effects of combined therapy with memantine, donepezil, and vitamin D in ovariectomized female mice subjected to dementia model.
    Vieira ADC; Medeiros EB; Zabot GC; Pereira NS; do Nascimento NB; Lidio AV; Scheffer ÂK; Rempel LCT; Macarini BMN; Costa MA; Gonçalves CL; Kucharska E; Rodrigues MS; Moreira JCF; de Oliveira J; Budni J
    Prog Neuropsychopharmacol Biol Psychiatry; 2023 Mar; 122():110653. PubMed ID: 36195205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Systematic Review on Donepezil-based Derivatives as Potential Cholinesterase Inhibitors for Alzheimer's Disease.
    Korabecny J; Spilovska K; Mezeiova E; Benek O; Juza R; Kaping D; Soukup O
    Curr Med Chem; 2019; 26(30):5625-5648. PubMed ID: 29768996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders.
    Lipton SA
    J Alzheimers Dis; 2004 Dec; 6(6 Suppl):S61-74. PubMed ID: 15665416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of cognitive deficits in a transgenic mouse model of Alzheimer's disease and effects of donepezil and memantine.
    Nagakura A; Shitaka Y; Yarimizu J; Matsuoka N
    Eur J Pharmacol; 2013 Mar; 703(1-3):53-61. PubMed ID: 23276665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
    Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
    Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiamnesic and neuroprotective effects of donepezil against learning impairments induced in mice by exposure to carbon monoxide gas.
    Meunier J; Ieni J; Maurice T
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1307-19. PubMed ID: 16551835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fenfluramine modulates the anti-amnesic effects induced by sigma-1 receptor agonists and neuro(active)steroids in vivo.
    Martin P; Maurice T; Gammaitoni A; Farfel G; Boyd B; Galer B
    Epilepsy Behav; 2022 Feb; 127():108526. PubMed ID: 35007961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possibility of a new anti-alzheimer's disease pharmaceutical composition combining memantine and vitamin D.
    Annweiler C; Beauchet O
    Drugs Aging; 2012 Feb; 29(2):81-91. PubMed ID: 22233455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anti-amnesic and neuroprotective effects of donepezil against amyloid beta25-35 peptide-induced toxicity in mice involve an interaction with the sigma1 receptor.
    Meunier J; Ieni J; Maurice T
    Br J Pharmacol; 2006 Dec; 149(8):998-1012. PubMed ID: 17057756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of Memantine and 6-Chlorotacrine as Novel Multi-Target Compound against Alzheimer's Disease.
    Kaniakova M; Nepovimova E; Kleteckova L; Skrenkova K; Holubova K; Chrienova Z; Hepnarova V; Kucera T; Kobrlova T; Vales K; Korabecny J; Soukup O; Horak M
    Curr Alzheimer Res; 2019; 16(9):821-833. PubMed ID: 30819076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathologically-activated therapeutics for neuroprotection: mechanism of NMDA receptor block by memantine and S-nitrosylation.
    Lipton SA
    Curr Drug Targets; 2007 May; 8(5):621-32. PubMed ID: 17504105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of σ
    Maurice T; Goguadze N
    Adv Exp Med Biol; 2017; 964():213-233. PubMed ID: 28315274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.